| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |